Drug Profile
Research programme: gp96-based vaccines - University of Miami/Zolovax
Latest Information Update: 05 May 2023
Price :
$50
*
At a glance
- Originator University of Miami
- Developer University of Miami; Zolovax
- Class Antimalarials; COVID-19 vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued COVID 2019 infections; Dengue; HIV infections; Malaria; West Nile virus infections; Yellow fever; Zika virus infection